
PPAR
Peroxisome Proliferator-Activated Receptors (PPARs) are a group of nuclear receptor proteins that function as transcription factors regulating the expression of genes involved in metabolism, particularly fatty acid storage and glucose metabolism. PPAR inhibitors are important tools for studying metabolic disorders such as diabetes, obesity, and cardiovascular diseases. These inhibitors can modulate lipid metabolism, insulin sensitivity, and inflammation, making them valuable in therapeutic research. At CymitQuimica, we offer a range of PPAR inhibitors to support your research in metabolic diseases, endocrinology, and drug development.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Rosiglitazone sodium REF: TM-T200945CAS: 316371-83-2 | - - - | To inquire | Fri 08 Aug 25 |
![]() | Lanifibranor REF: TM-T7395CAS: 927961-18-0 | 99.25% - 99.3% | - - - | Discontinued product |

Rosiglitazone sodium
Ref: TM-T200945
10mg | To inquire | ||
50mg | To inquire |

Lanifibranor
Ref: TM-T7395
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
500mg | Discontinued | Request information | |
1mL*10mM (DMSO) | Discontinued | Request information |